£790.00

The 2025-2030 World Outlook for Sickle Cell Anemia Treatments

Subjects

Price data checked 7 days ago

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£790 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 84 days · 84 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 84 days • 1 price levels

Days at Price

Price Analysis

Most common price: £790 (84 days, 100.0%)

Price range: £790 - £790

Price levels: 1 different prices over 84 days

Description

This study covers the world outlook for sickle cell anemia treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of sickle cell anemia treatments as including all commonly understood products and/or services falling within this broad category, such as branded therapy, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Aegerion Pharmaceuticals, Alexion, Amicus Therapeutics, Biomarin, F. Hoffmann-La Roche, and Onyx Pharmaceuticals. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2024).

Product Specifications

Format: paperback
ASIN: B0CZM21KNZ
Category: Books > Subjects
Domain: Amazon UK
Release Date: 03 March 2024
Listed Since: 08 May 2024

The 2025-2030 World Outlook for Sickle Cell Anemia Treatments

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Similar Products You Might Like

The 2023-2028 World Outlook for Sickle Cell Anemia Treatments

The 2023-2028 Outlook for Sickle Cell Disease Treatments in India

Current Practices in Sickle Cell Disease

Young ∗aplastic∗ Anemia – Stem Cell Biology And Advances In Treatment

Sickle Cell Syndromes, An Issue of Hematology/Oncology Clinics of North America: Volume 36-6 (The Clinics: Internal Medicine, Volume 36-6)

The 2023-2028 Outlook for Iron Deficiency Anemia Therapies in India

The 2023-2028 Outlook for Iron Deficiency Anemia Drugs in India

The 2023-2028 Outlook for Iron Deficiency Anemia Therapies in the United States

The 2023-2028 World Outlook for Iron Deficiency Anemia Therapies

The 2016-2021 World Outlook for In-Vitro Diagnostic Hematology Products

The Social Meanings of SCD in Ghana: Fathers’ Reactions & Perspectives: The Social Meanings of a Child with Sickle Cell Disease Among Fathers in Ghana

The 2023-2028 Outlook for Iron Deficiency Anemia Drugs in the United States

The 2016-2021 Outlook for Hematology Instruments and Reagents in the United States

The 2021-2026 World Outlook for Hematology Analyzers

The 2016-2021 Outlook for Hematology Instruments and Reagents in Japan

The 2016-2021 Outlook for Hematology Analyzers in Japan

The 2016-2021 Outlook for Hematology Instruments and Reagents in India

The 2016-2021 Outlook for Hematology Instruments and Reagents in Greater China

The 2023-2028 World Outlook for Hematologic Malignancies

The 2016-2021 Outlook for Hematology Analyzers in India

The 2023 Report on Iron Deficiency Anemia Therapies: World Market Segmentation by City

Current Topics in Anemia

The 2023-2028 Outlook for Iron Deficiency Anemia Therapies in China

The 2023-2028 Outlook for Oral Iron Therapy for Iron Deficiency Anemia in India